Brevan Howard Capital Management LP Recursion Pharmaceuticals, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 21,096 shares of RXRX stock, worth $155,055. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,096Holding current value
$155,055% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
260Shares Held
192MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$181 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$177 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$118 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$90.6 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$76.5 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.33B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...